SKK
AMAG

Shepherd Kaplan Krochuk’s AMAG Pharmaceuticals AMAG Stock Holding History

Shepherd Kaplan Krochuk’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-8,675
Closed -$302K – 299
2016
Q4 		$302K Sell
8,675
-12,326
-59% -$368K 0.09% 126
2016
Q3 		$515K Hold
21,001
– – 0.11% 132
2016
Q2 		$502K Hold
21,001
– – 0.12% 109
2016
Q1 		$491K Buy
+21,001
New +$498K 0.15% 95
2015
Q4 		– Sell
-9,416
Closed -$374K – 446
2015
Q3 		$374K Sell
9,416
-4,126
-30% -$256K 0.1% 160
2015
Q2 		$935K Buy
13,542
+1,388
+11% +$87.3K 0.18% 96
2015
Q1 		$664K Sell
12,154
-8,181
-40% -$390K 0.12% 139
2014
Q4 		$867K Hold
20,335
– – 0.14% 145
2014
Q3 		$649K Buy
20,335
+8,513
+72% +$182K 0.08% 175
2014
Q2 		$245K Hold
11,822
– – 0.03% 407
2014
Q1 		$229K Hold
11,822
– – 0.03% 417
2013
Q4 		$287K Sell
11,822
-9,950
-46% -$234K 0.04% 334
2013
Q3 		$468K Buy
21,772
+6,805
+45% +$161K 0.08% 209
2013
Q2 		$333K Buy
+14,967
New +$330K 0.07% 268

Other funds holding AMAG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Shepherd Kaplan Krochuk's AMAG Position: Q1 2017 in Review

Shepherd Kaplan Krochuk sold out of AMAG Pharmaceuticals (AMAG) in Q1 2017, closing a stake of 8,675 shares — an estimated $302K sold.

Shepherd Kaplan Krochuk first reported a position in AMAG in Q2 2013 and held it in 14 quarters. The position peaked at $935K in Q2 2015. 185 funds tracked by Wall St. Rank hold AMAG as of Q1 2017.

  • Shepherd Kaplan Krochuk reported no remaining AMAG Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
  • Shepherd Kaplan Krochuk sold 8,675 AMAG Pharmaceuticals shares in Q1 2017, an estimated $302K.
  • Shepherd Kaplan Krochuk first reported a position in AMAG Pharmaceuticals in Q2 2013 and held it in 14 quarters.
  • Shepherd Kaplan Krochuk's AMAG Pharmaceuticals position peaked at $935K in Q2 2015.
  • 185 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q1 2017.

Based on Shepherd Kaplan Krochuk's 13F filing for Q1 2017, filed 12 May 2017.